A company called Analog Devices might have its price go up by about 19%. Some smart people who study stocks made predictions about how much money the company's shares will be worth. These are called "analyst forecasts". Read from source...

Analyst ratings are notoriously unreliable and often influenced by personal agendas or market manipulation. The article does not provide any evidence to support the claims made by the analysts or their forecasts. It is important for readers to question the motives behind these predictions and consider alternative sources of information before making investment decisions.

DAN: Based on the information provided, I have analyzed the following stocks: Wix.com Ltd., Analog Devices Inc., Glaukos Corporation. Here are my suggestions for each of them:

Wix.com Ltd.: This is a cloud-based web development platform that allows users to create and design websites without coding. The company has a strong growth potential due to the increasing demand for online presence and digital transformation. However, there are also some risks involved, such as competition from other platforms like Squarespace, WooCommerce, and Shopify, as well as regulatory challenges in some markets. Therefore, I would recommend a moderate investment in this stock, with a target price of $165, which is the updated price target by Piper Sandler. The expected return is around 17%, and the risk-reward ratio is favorable.

Analog Devices Inc.: This is a semiconductor company that designs and manufactures analog and mixed-signal products for various applications, such as communications, industrial, automotive, and consumer electronics. The company has a diversified customer base and a strong market position in the analog space. However, there are also some challenges ahead, such as the global chip shortage, the impact of the COVID-19 pandemic on demand, and the competition from other players like Texas Instruments, NXP Semiconductors, and Microchip Technology. Therefore, I would recommend a conservative investment in this stock, with a target price of $230, which is the updated price target by Keybanc. The expected return is around 17%, and the risk-reward ratio is balanced.

Glaukos Corporation: This is an ophthalmic medical device company that focuses on developing and commercializing innovative products for glaucoma, one of the leading causes of blindness worldwide. The company has a unique portfolio of therapies that aim to reduce the intraocular pressure and preserve the vision of millions of patients. However, there are also some uncertainties in the market, such as the pricing pressures, the reimbursement issues, and the regulatory hurdles. Therefore, I would recommend a speculative investment in this stock, with a target price of $108, which is the updated price target by Needham. The expected return is around 7%, and the risk-reward ratio is high.